There's a lot that we don't know about what influences the pathology of getting type 2 diabetes, but there are some things that we do know, and do know quite a bit about actually. Regardless of the myriad of influences upon the progression of this disease, there is one that is central and the cornerstone of type 2 diabetes actually, and that's excessive insulin levels.
In spite of our knowledge about this, insulin levels for the most part are ignored, and have not been accepted at all by conventional medical thinking in spite of all the science we have on it. Conventional medicine really isn't that interested in science generally, only science that can at least be interpreted, even incorrectly interpreted, as propping up their current views and protocols.
To be more blunt, this is actually essentially a business, and a big business at that, measured in the trillions of dollars. Information, no matter how sound, that doesn't further their goals, which are at the deepest levels profit oriented, are cast off. The truth here isn't what's being sought, it's more a matter of business oriented public relations.
Treatments that don't work are preferred actually, especially if a dependence can be created. A great example of this is taking people whose insulin levels are already too high and whose diabetes has progressed as a result, and giving them even more insulin, which accelerates the progression of the diabetes by worsening the underlying disease behind it, hyperinsulinemia, although that disease remains behind the curtain and ensures that patients will get worse over time and become even more reliant on medication to manage their blood sugar.
With that said though, we're actually talking about before all of this right now, in the earlier stages of diabetes, where one suffers from just the hyperinsulinemia and not hyperglycemia, yet.
So concerns about hyperinsulemia are swept under the rug, and you can go to a lot of sources where you get the idea that this is some sort of rare condition, caused by things like tumors of the pancreas, which is not only patently false but ridiculous. They are able to do this because they just set the clinical standard so high that few people have levels high enough to qualify for their benchmark, as they do with things like cortisol, where they only care about the extreme levels of high or low, Addison's or Cushings, and that actually makes sense because this is where the use of their meds are considered appropriate, and meds is all they have.
So this ends up throwing a lot of people under the bus, they may be suffering from pathogenically low or high cortosol levels, an adrenal hormone, and can be very sick indeed but they don't make the grade for the meds so they are just told that nothing is wrong with them and sent home.
It's even worse with insulin levels though, people aren't being tested and then sent home because they don't fall 2 standard deviations from the norm, a statistical model that only looks at extremes, and by the way, to the extent that most people are sick from something, normal itself may even indicate illness.
With insulin, well they have a better plan, just don't test people for this period. This is a pretty standard lab test by the way but it's generally only used to see if people are type 1's, to see if you're making at least some insulin, and if you are, well all is well, congratulations.
So while we officially have to call the kind of high insulin levels we're talking about subclinical hyperinsulinemia, the same way that we have to talk about subclinically high or low cortisol, but being subclinical has nothing to do with its effect on disease, there isn't some magic point in time that just happens to correspond with 2 standard deviations from normal that you go from being OK to having a disease, that's ridiculous.
I'll continue this in the next article where we'll look at some actual clinical numbers, as although very few doctors measure insulin and even fewer have much of a clue at all why this even matters, there's one famous exception, Dr. Joseph Kraft, who dedicated his career to this, even though his voice remains very seldom heard.